0 CHECKOUT

Clinical Trial Supplies Market by Products & Services, Phases & Therapeutic Areas - Global Forecast to 2020

  • ID: 3440212
  • October 2015
  • Region: Global
  • 134 Pages
  • Markets and Markets
1 of 4
The Global Clinical Trial Supplies Market Is Expected to Reach USD 1,274.3 Million by 2020

FEATURED COMPANIES

  • ALMAC Group Ltd,
  • Biocair
  • Klifo A/S.
  • Movianto
  • Parexel International
  • Patheon, Inc.
  • MORE

The global market is broadly classified into manufacturing services, packaging and labeling services, and logistics and distribution services. The logistics and distribution segment is expected to account for the largest share of the global clinical trial supplies products market in 2015.

On the basis of phases, the clinical trial supplies market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of the global market in 2015. On the basis of therapeutic areas, the clinical trial supplies market has been segmented into oncology, cardiovascular and metabolic disorders, respiratory diseases, CNS and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the global market in 2015.

Geographically, the clinical trial supplies market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising prevalence of patients suffering from chronic diseases, growing number of clinical trials, and the increasing number READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ALMAC Group Ltd,
  • Biocair
  • Klifo A/S.
  • Movianto
  • Parexel International
  • Patheon, Inc.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Key Industry Insights
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Clinical Trial Supplies Market
4.2 Market Share, Services vs Regions
4.3 Geographic Analysis: Clinical Trial Supplies Market, By Phase
4.4 Geographic Analysis: Market, By Product
4.5 Lifecycle Analysis, By Region

5 Market Overview
5.1 Introduction
5.2 Clinical Trial Supplies: Market Segmentation
5.2.1 By Products and Services
5.2.2 By Phase
5.2.3 By Therapeutic Area
5.2.4 By Region
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Globalization of Clinical Trial Activities
5.3.1.2 Increasing R&D Investments and Government Support
5.3.1.3 Rising Incidences of Various Diseases
5.3.1.4 Increasing Expansion Activities By Cros
5.3.2 Market Restrains
5.3.2.1 Longer Approval Times for Clinical Trials
5.3.3 Opportunities
5.3.3.1 Emerging Markets
5.3.3.2 Increasing Number of Patent Expirations and Development of Generic Drugs
5.4 Industry Trends
5.4.1 Just-In-Time Packaging and Labeling Methods for Clinical Trial Supplies

6 Clinical Trial Supplies Market, By Product and Service
6.1 Introduction
6.2 Manufacturing
6.3 Packaging and Labeling
6.4 Logistics and Distribution

7 Clinical Trial Supplies Market, By Phase
7.1 Introduction
7.2 Phase I
7.3 Phase II
7.4 Phase III and Bioequivalence Studies

8 Clinical Trial Supplies Market, By Therapeutic Area
8.1 Introduction
8.2 Oncology
8.3 Cns and Mental Disorders
8.4 Cardiovascular Diseases
8.5 Infectious Diseases
8.6 Respiratory Diseases
8.7 Blood Disorders
8.8 Dermatology
8.9 Others

9 Clinical Trial Supplies Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe (Roe)
9.4 Asia-Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.5 Rest of the World (RoW)

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situations and Trends
10.3.1 Expansion
10.3.2 Agreements, Partnerships, Collaborations, and Joint Venture
10.3.3 Acquisitions
10.3.4 New Product and Service Launches
10.3.5 Others

11 Company Profiles
(Overview, Financials, Products & Services, and Developments)*
11.1 Introduction
11.2 ALMAC Group Ltd,
11.3 Catalent Pharma Solutions, Inc.
11.4 Parexel International
11.5 Thermo Fisher Scientific, Inc.
11.6 PCI Services
11.7 Patheon, Inc.
11.8 Sharp Packaging Services
11.9 Biocair
11.10 Movianto
11.11 Klifo A/S.

*Details on Overview, Financials, Product & Services, and Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports

List of Tables
Table 1 Increasing Expansion Activities By Cros to Boost the Market Growth for Clinical Trial Supplies
Table 2 Longer Approval Times for Clinical Trials are Restraining the Growth of the Market
Table 3 Growth Prospects in Emerging Countries to Fuel the Market Growth
Table 4 Clinical Trial Supplies Market Size, By Product and Service, 2013-2020 (USD Million)
Table 5 Market Size, By Region, 2013-2020 (USD Million)
Table 6 North America: Market Size, By Country, 2013-2020 (USD Million)
Table 7 Europe: Market Size, By Country, 2013-2020 (USD Million)
Table 8 Asia-Pacific: Market Size, By Country, 2013-2020 (USD Million)
Table 9 Clinical Trial Supplies Market Size for Manufacturing Services, By Region, 2013-2020 (USD Million)
Table 10 North America: Market Size for Manufacturing Services, By Country, 2013-2020 (USD Million)
Table 11 Europe: Market Size for Manufacturing Services, By Country, 2013-2020 (USD Million)
Table 12 Asia-Pacific: Market Size for Manufacturing Services, By Country, 2013-2020 (USD Million)
Table 13 Clinical Trial Supplies Market Size for Packaging and Labeling Services, By Region, 2013-2020 (USD Million)
Table 14 North America: Market Size for Packaging and Labeling Services, By Country, 2013-2020 (USD Million)
Table 15 Europe: Market Size for Packaging and Labeling Services, By Country, 2013-2020 (USD Million)
Table 16 Asia-Pacific: Market Size for Packaging and Labeling Services, By Country, 2013-2020 (USD Million)
Table 17 Clinical Trial Supplies Market Size for Logistics and Distribution Services, By Region, 2013-2020 (USD Million)
Table 18 North America: Market Size for Logistics and Distribution Services, By Country, 2013-2020 (USD Million)
Table 19 Europe: Market Size for Logistics and Distribution Services, By Country, 2013-2020 (USD Million)
Table 20 Asia-Pacific: Market Size for Logistics and Distribution Services, By Country, 2013-2020 (USD Million)
Table 21 Clinical Trial Supplies Market Size, By Phase, 2013-2020 (USD Million)
Table 22 Market Size, By Region, 2013-2020 (USD Million)
Table 23 North America: Market Size, By Country, 2013-2020 (USD Million)
Table 24 Clinical Trial Supplies Market Size for Phase I Trials, By Region, 2013-2020 (USD Million)
Table 25 North America: Market Size for Phase I Trials, By Country, 2013-2020 (USD Million)
Table 26 Clinical Trial Supplies Market Size for Phase II Trials, By Region, 2013-2020 (USD Million)
Table 27 North America: Market Size for Phase II Trials, By Country, 2013-2020 (USD Million)
Table 28 Clinical Trial Supplies Market Size for Phase III Trials, By Region, 2013-2020 (USD Million)
Table 29 North America: Market Size for Phase III Trials, By Country, 2013-2020 (USD Million)
Table 30 Clinical Trial Supplies Market Size, By Therapeutic Area, 2013-2020 (USD Million)
Table 31 Clinical Trial Supplies Market Size, By Region, 2013-2020 (USD Million)
Table 32 Market Size for Oncology, By Region, 2013-2020 (USD Million)
Table 33 Market Size for Cns and Mental Disorders, By Region, 2013-2020 (USD Million)
Table 34 Market Size for Cardiovascular Diseases, By Region, 2013-2020 (USD Million)
Table 35 Market Size for Infectious Diseases, By Region, 2013-2020 (USD Million)
Table 36 Market Size for Respiratory Diseases, By Region, 2013-2020 (USD Million)
Table 37 Market Size for Blood Disorders, By Region, 2013-2020 (USD Million)
Table 38 Market Size for Dermatology, By Region, 2013-2020 (USD Million)
Table 39 Clinical Trial Supplies Market for Other Applications, By Region, 2013-2020 (USD Million)
Table 40 North America: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 41 North America: Market Size, By Phase, 2013-2020 (USD Million)
Table 42 North America: Market Size, By Therapeutic Area, 2013-2020 (USD Million)
Table 43 U.S.: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 44 U.S.: Market Size, By Phase, 2013-2020 (USD Million)
Table 45 Canada: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 46 Canada: Market Size, By Phase, 2013-2020 (USD Million)
Table 47 Europe: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 48 Europe: Market Size, By Phase, 2013-2020 (USD Million)
Table 49 Europe: Market Size, By Therapeutic Area, 2013-2020 (USD Million)
Table 50 U.K.: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 51 Germany: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 52 France: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 53 Spain: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 54 Italy: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 55 Roe: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 56 Asia-Pacific: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 57 Asia-Pacific: Market Size, By Phase, 2013-2020 (USD Million)
Table 58 Asia-Pacific: Market Size, By Therapeutic Area, 2013-2020 (USD Million)
Table 59 China: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 60 India: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 61 Japan: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 62 RoAPAC: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 63 RoW: Market Size, By Products & Services, 2013-2020 (USD Million)
Table 64 RoW: Market Size, By Phase, 2013-2020 (USD Million)
Table 65 RoW: Market Size, By Therapeutic Area, 2013-2020 (USD Million)
Table 66 Expansions, 2012-2015
Table 67 Agreements, Partnerships, Collaborations, and Joint Venture, 2012-2015
Table 68 Acquisitions, 2012-2015
Table 69 New Product and Service Launches, 2012-2015
Table 70 Others, 2012-2015

List of Figures
Figure 1 Clinical Trial Supplies Market
Figure 2 Research Design
Figure 3 Top-Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, & Region
Figure 6 Data Triangulation Methodology
Figure 7 Clinical Trial Products and Services Market Snapshot, 2015 vs 2020
Figure 8 North America to Dominate the Logistics and Distribution Market From 2015 to 2020
Figure 9 Oncology Segment to Command the Largest Market Share and is Expected to Witness the Highest Growth Rate During the Forecast Period
Figure 10 Phase III to Dominate the Clinical Trial Supplies Market From 2015 to 2020
Figure 11 Clinical Trial Supplies Market, By Region, 2015
Figure 12 Asia-Pacific Region to Witness Highest Growth Rate in the Clinical Trial Supplies Market From 2015 to 2020
Figure 13 Clinical Trial Supplies Market to Showcase Lucrative Growth Opportunities in the Forecast Period
Figure 14 Logistics and Distribution Segment to Account for the Largest Market Share in 2015
Figure 15 Phase III Segment to Grow at the Highest Rate During the Forecast Period
Figure 16 Logistics and Distribution Will Continue to Lead the Market in the Forecast Period
Figure 17 Asia-Pacific Market for Clinical Trial Supplies to Grow at the Highest Rate During the Forecast Period
Figure 18 Market: Drivers, Restraints, and Opportunities
Figure 19 Logistics and Distribution Services Segment Expected to Grow at the Highest CAGR in the Forecast Period
Figure 20 North America Expected to Dominate the Market for Manufacturing Services in the Forecast Period
Figure 21 Phase III Segment is Expected to Dominate the Market in the Forecast Period
Figure 22 Oncology Segment Dominates the Market in 2015
Figure 23 North America Dominates the Oncology Market in 2015
Figure 24 Geographic Snapshot: Emerging Markets Hold Significant Growth Opportunities in the Forecast Period
Figure 25 North America: Market Snapshot
Figure 26 Phase III Segment Will Drive the Growth of the Market in the U.S. in the Forecast Period
Figure 27 Germany is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 28 Asia-Pacific: Market Snapshot
Figure 29 Expansion Was the Major Strategy Adopted Between 2012 and 2015
Figure 30 Market Share, By Key Player, 2014
Figure 31 Battle for Market Share: Expansion, the Most Actively Adopted Strategy By Market Players
Figure 32 Product Benchmarking for Major Players
Figure 33 Catalent Pharma Solutions, Inc.: Company Snapshot
Figure 34 Parexel International: Company Snapshot
Figure 35 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 36 Sharp Packaging Services: Company Snapshot

Note: Product cover images may vary from those shown
3 of 4

- ALMAC Group Ltd,
- Biocair
- Catalent Pharma Solutions, Inc.
- Klifo A/S.
- Movianto
- PCI Services
- Parexel International
- Patheon, Inc.
- Sharp Packaging Services
- Thermo Fisher Scientific, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

ALSO AVAILABLE

RELATED PRODUCTS from Db

Our Clients

  • Pharmaceutical Product Development
  • Quintiles Transnational
  • Covance Inc.
  • Charles River
  • Accovion
  • INC Research